MORE►
National Conservancy
Volunteer scouts team up to carry water to trees that were planted in South Dallas. [Photo: Mark Graham/The Nature Conservancy]
If You Can’t Take the Heat, Plant More Trees: The Cool and Connected Oak Cliff Project
by Lauren Hawkins | Oct 5, 2018
The urban "heat island" effect has major consequences on the quality of Dallas life. This project is planting trees to lessen the effect's impact.
Related Articles
The Last Word: On CFT’s ‘North Texas Gives to the Arts’ Fundraising Campaign
Calendar: Not-to-Miss Events for Innovators in Dallas-Fort Worth
Apply Now:
Opportunities for North Texas Innovators Fair Park’s Planned Community Park To Get Nearly $2.6M from NexPoint Philanthropies, Texas Parks & Wildlife EarthX Announces 2025 Climate Tech Prize Semifinalists, Ocean Exchange Pitch
Opportunities for North Texas Innovators Fair Park’s Planned Community Park To Get Nearly $2.6M from NexPoint Philanthropies, Texas Parks & Wildlife EarthX Announces 2025 Climate Tech Prize Semifinalists, Ocean Exchange Pitch
MORE►
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
